Literature DB >> 6282261

The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments.

G J Arlaud, J Gagnon, R R Porter.   

Abstract

1. The a- and b-chains of reduced and alkylated human complement subcomponent C1r were separated by high-pressure gel-permeation chromatography and isolated in good yield and in pure form. 2. CNBr cleavage of C1r b-chain yielded eight major peptides, which were purified by gel filtration and high-pressure reversed-phase chromatography. As determined from the sum of their amino acid compositions, these peptides accounted for a minimum molecular weight of 28 000, close to the value 29 100 calculated from the whole b-chain. 3. N-Terminal sequence determinations of C1r b-chain and its CNBr-cleavage peptides allowed the identification of about two-thirds of the amino acids of C1r b-chain. From our results, and on the basis of homology with other serine proteinases, an alignment of the eight CNBr-cleavage peptides from C1r b-chain is proposed. 4. The residues forming the 'charge-relay' system of the active site of serine proteinases (His-57, Asp-102 and Ser-195 in the chymotrypsinogen numbering) are found in the corresponding regions of C1r b-chain, and the amino acid sequence around these residues has been determined. 5. The N-terminal sequence of C1r b-chain has been extended to residue 60 and reveals that C1r b-chain lacks the 'histidine loop', a disulphide bond that is present in all other known serine proteinases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282261      PMCID: PMC1163608          DOI: 10.1042/bj2010049

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  The phylogeny of trypsin-related serine proteases and their zymogens. New methods for the investigation of distant evolutionary relationships.

Authors:  C de Haën; H Neurath; D C Teller
Journal:  J Mol Biol       Date:  1975-02-25       Impact factor: 5.469

2.  Activation of C1r by proteolytic cleavage.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

3.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

4.  C1r, subunit of the first complement component: purification, properties, and assay based on its linking role.

Authors:  M M De Bracco; R M Stroud
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

5.  Isolation and characterization of the proenzyme form of the C1r subunit of the first complement component.

Authors:  G Valet; N R Cooper
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Physicochemical and functional characterization of the C1r subunit of the first complement component.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

8.  A gross structure of an activated form of a subunit of the first component of human complement. Clr.

Authors:  K Takahashi; S Nagasawa; J Koyama
Journal:  FEBS Lett       Date:  1975-07-15       Impact factor: 4.124

9.  Separation of dansyl-amino acids by polyamide layer chromatography.

Authors:  K R Woods; K T Wang
Journal:  Biochim Biophys Acta       Date:  1967-02-21

10.  The enzymatic nature of C'1r. Conversion of C'1s to C'1 esterase and digestion of amino acid esters by C'1r.

Authors:  G B Naff; O S Ratnoff
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

View more
  9 in total

1.  CNBr cleavage of the light chain of human complement factor I and alignment of the fragments.

Authors:  J M Yuan; L M Hsiung; J Gagnon
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

2.  Autoactivation of human complement subcomponent C1r involves structural changes reflected in modifications of intrinsic fluorescence, circular dichroism and reactivity with monoclonal antibodies.

Authors:  C L Villiers; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1983-11-01       Impact factor: 3.857

3.  Neutron scattering studies of the isolated C1r2C1s2 subunit of first component of human complement in solution.

Authors:  J Boyd; D R Burton; S J Perkins; C L Villiers; R A Dwek; G J Arlaud
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

4.  Purification of human C3b inactivator by monoclonal-antibody affinity chromatography.

Authors:  L Hsiung; A N Barclay; M R Brandon; E Sim; R R Porter
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

5.  Complete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1r.

Authors:  G J Arlaud; A C Willis; J Gagnon
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

6.  Primary structure of the A chain of human complement-classical-pathway enzyme C1r. N-terminal sequences and alignment of autolytic fragments and CNBr-cleavage peptides.

Authors:  J Gagnon; G J Arlaud
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

7.  The serine proteinase chain of human complement component C1s. Cyanogen bromide cleavage and N-terminal sequences of the fragments.

Authors:  P E Carter; B Dunbar; J E Fothergill
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

8.  Amino acid sequence of the Bb fragment from complement Factor B. Sequence of the major cyanogen bromide-cleavage peptide (CB-II) and completion of the sequence of the Bb fragment.

Authors:  D L Christie; J Gagnon
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

Review 9.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.